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Abstract Although not formally recognized by the DSM-
5, food addiction (FA) has been well described in the sci-
entific literature. FA has emerged as a clinical entity that is
recognized within the spectrum of disordered eating, par-
ticularly in patients with bulimia nervosa, binge-eating
disorder and/or co-occurring addictive disorders and obe-
sity. Integrating the concept of FA into the scope of dis-
ordered eating has been challenging for ED treatment
professionals, since there is no well-accepted treatment
model. The confusion surrounding the implications of FA,
as well as the impact of the contemporary Westernized
diet, may contribute to poor treatment outcomes. The
purpose of this review is twofold. The first is to briefly
explore the relationships between EDs and addictions, and
the second is to propose a new model of conceptualizing
and treating EDs that incorporates recent data on FA. Since
treatment for EDs should vary based on individual
assessment and diagnosis, the Disordered Eating Food
Addiction Nutrition Guide (DEFANG) is presented as a
tool for framing treatment goals and helping patients
achieve sustainable recovery.
Keywords Anorexia nervosa  Binge-eating disorder 
Bulimia nervosa  Eating disorder  Food addiction 
Substance use disorder
Introduction
The classic prototype of a person with an eating disorder
(ED) is a middle class young white female with anorexia
nervosa (AN). However, recent prevalence data indicate
that EDs are common in both genders, occur at all ages, in
all races, and affect all income levels [1]. In the past
decade, EDs have been reported across wider demograph-
ics due to factors such as increased awareness, changing
societal values, targeted research, and an evolving Western
diet. With the sharp rise in substance use disorders (SUDs),
mental health professionals are seeing increased numbers
of patients with both SUD and ED. While the interaction
between SUDs and EDs is not fully understood, there are
bidirectional associations in research conducted on females
with AN and bulimia nervosa (BN) [2, 3]. Evidence linking
binge-eating disorder (BED) to addiction (alcohol, drug,
food) has strengthened in recent years, although consider-
able controversy remains about the nature of this associa-
tion. In a recent textbook, Brewerton and Dennis [4]
explored links and correlations between EDs, SUDs, and
addictions across genetic, neurobiological, and behavioral
domains, and advocated for an integrated treatment
approach. Frank [5] suggests that a ‘‘dimensional approach
that identifies neurobiological underpinnings of psychiatric
disease based on specific behavioral constructs may help
eventually develop more accurate models of EDs and
identify empirically more specific and effective biological
treatments’’.
Although not formally recognized by the DSM-5, food
addiction (FA) has been well described in the ED and
obesity literature, and a recent meta-analysis reported that
20% of all subjects (60% were female and overweight/
obese) tested for FA met criteria based on the Yale Food
Addiction Scale (YFAS) [6]. Incorporating the concept of
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FA into the spectrum of disordered eating has been difficult
for ED treatment professionals for a variety of reasons,
including training suggesting that EDs are unique disorders
distinct from addictions, the dogmatic belief that there are
‘‘no bad foods’’ (everything in moderation), and because
there is no well-established treatment for FA. Several
authors have recommended the application of traditional
addiction treatment [7] including psychiatric interventions
[8] as well as reduced exposure to addictive foods [9, 10].
An alternative approach advocates reducing exposure to
restrictive eating (dieting) since it may perpetuate the cycle
of disordered eating [11, 12]. Many ED professionals are
uneasy conceptualizing EDs as a form of addiction, since
the classic eating disorder AN restricting type (AN-R) does
not resemble an addictive disorder (although it can be
argued that ‘‘starvation’’ can become addictive) [13, 14].
Unfortunately, standard ED treatment is associated with
high rates of relapse and poor long-term remission rates
[15]. Some authors believe that existing treatments fail
because they do not address impulsivity as a core factor of
eating pathology [16]. The confusion surrounding the
concept of FA, as well as the impact of the contemporary
Westernized diet, may contribute to poor treatment out-
comes. The purpose of this paper is twofold. The first is to
explore the relationships between FA, SUDs and EDs, and
the second to propose a new model of conceptualizing and
treating EDs that incorporates recent data on addiction.
The Disordered Eating Food Addiction Nutrition Guide
(DEFANG) was developed for clinical application at
treatment facilities for FA, SUDs, EDs, and related disor-
ders, such as post-traumatic stress disorder (PTSD). The
objective is to plot patient symptoms onto a diagram
(outside of the circle, inside of the square) in order to craft
effective, individualized intervention strategies (see
Fig. 1). Since classic ED treatment does not typically
acknowledge the gravity of addictive processes (including
food), patients with addictions report struggling with
messages that are inconsistent with their experience (e.g.,
‘‘eat all foods in moderation’’). The generic message of
‘‘moderation’’ is subjective (perceived), remains poorly
defined, contains self-serving biases, and appears to reduce
self-conflict around over-consumption of food [17]. While
reduction of self-conflict (e.g., shame) is critical for ED
recovery and the development of a sustainable relationship
to food, the misinterpretation and misapplication of
‘‘moderation’’ can become counter-productive, particularly
when there is addictive symptomatology. The DEFANG is
designed to minimize inconsistent messaging from the
treatment team by necessitating that the psychiatrist, ther-
apists, dietitians, and supporting staff reach an agreement
about the patient’s diagnosis and ‘‘big picture’’ treatment
goals. Multidisciplinary staff can plot patients on the
DEFANG based on their own assessment and then reach a
consensus. Additionally, patients can be educated on the
use of the DEFANG and invite them to plot themselves on
the diagram, which enables self-assessment to be part of
their treatment plan. Patients should be instructed that not
all ED cases require the same treatment approach, which
may decrease comparisons that can plague an ED unit.
Anorexia nervosa (AN)
The DSM-5 diagnostic criteria for AN include an intense
fear of gaining weight or becoming fat, and persistent
behavior that interferes with weight gain, even at a sig-
nificantly low weight [18]. Appearance concerns that are
not weight related (e.g., skin, nose, body hair, teeth) have
also been reported in individuals with AN. Among females
with AN, the restricting type is less likely to have an SUD
than the binge-eating/purging-type [19], which may be due
to higher rates of impulsivity associated with bulimic
symptomatology [20]. Impulsivity is less common in AN
than in other EDs and may be a predictor of those with AN-
R who cross over into binge/purge behavior (AN-BP) [21].
Thus, diagnostic crossover between different EDs is pre-
dictable, particularly with AN-BP, BN, and BED. Women
with AN may engage in substances initially in an effort to
lose weight, whereas women with BN may turn to drugs or
alcohol to subdue bulimic urges [2]. The caloric contri-
bution of alcoholic beverages may deter patients with AN
from excessive use, although controlled and calculated
consumption is not uncommon. Of all the EDs, AN-R is the
least compatible with SUDs since individuals with AN-R
maintain the ability to consistently abstain, are less likely
to exhibit cravings, and may not experience impaired
behavioral control [13]. While it can be argued that AN-R
may be a form of starvation dependence or dieting addic-
tion, this is yet to be established. Thus, AN sits on the
opposite spectrum of FA (see Fig. 1), and for many of
these patients the disorder is less ‘‘about the food’’ and
more related to underlying psychological factors, i.e.,
irrational fears, distorted perceptions and beliefs (likely
unrelated to food addiction), which varies from patient to
patient. However, FA symptomatology has been reported
in patients with AN-BP [22], further establishing the need
to look at these disorders on a continuum.
Bulimia nervosa (BN)
Individuals with BN have an altered sense of self-evalua-
tion which is unduly influenced by body shape and weight
[18], and share the characteristic body image disturbance
with AN. While similarities between AN-R and BN exist,
there are clear differences such as the ability to consistently
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control eating, whereas AN-BP and BN more closely
resemble one another. Patients with BN compensate for
their loss of control around food through various forms of
purging, fasting, or excessive exercise, usually in an effort
to prevent weight gain. BN results in altered reward sen-
sitivity in the dopaminergic brain system, which may
increase addictive potential [23]. Muele [24] speculates
that many bulimics who are in a normal weight range may
be food addicts. Associations between BN and alcohol use
disorders (AUDs) have been linked to common genetic
influences [25]. Similarly, overlap between BN and SUDs
has been attributed to genetic more than environmental
factors [26]. Alcohol consumption that reduces food crav-
ings in BN may be due to increased satiety, reduced
attention to eating-related urges, or simply by improving
mood [27]. Nonmedical prescription stimulant abuse used
for appetite suppression and weight loss has been associ-
ated ED symptomatology including bingeing and purging
[28]. Thus, SUD (including alcohol) is identified as a
characteristic overlapping with BN (see Fig. 1).
It remains unclear if the addictive symptomatology in
BN patients is more closely associated with the eating or
the compensatory behaviors [29]. The DSM-5 now recog-
nizes a purging disorder, which occurs in the absence of
binge eating, suggesting that purging by itself can be a
rewarding experience (also evidenced by AN-P). The
apparent overlap between BN and FA suggests that
reducing exposure to addictive foods may be effective in
the treatment of BN [29]. Research has shown that the top
fifteen foods considered to be most addictive by individuals
with FA include chocolate, ice cream, French fries, pizza,
cookies, chips, cake, popcorn, cheeseburgers, muffins,
breakfast cereal, gummy candy, fried chicken, sugary soda,
and rolls [30]. All these highly palatable foods are pro-
cessed foods and are noted to share pharmacokinetic
properties with drugs of abuse, such as concentrated dose
and rapid rate of absorption. However, the traditional
nutritional approach to BN has been to liberalize the diet,
given that food restriction may increase reward sensitivity
[31] and promote rebound bingeing. Umberg et al. [23]





Eat Weight Disord (2017) 22:49–59 51
123
proposed that BN may be separated into two distinct sub-
types that recognize patients who are hyporesponsive to
reward (akin to AN) versus those with hypersensitive
reward circuitry (akin to FA). This distinction separates
those with BN into two groups that would warrant different
treatment approaches (Fig. 1).
Binge-eating disorder (BED)
Important diagnostic components of BED include impair-
ment and distress [18], which may come in the form of
anxiety [32]. Body dissatisfaction, shame, severe self-
criticism, social comparison, stress, and trauma are com-
mon in BED, as well as in BN and AN (especially AN–BP
subtype), and have been identified as underlying mecha-
nisms behind binge behaviors [33–36]. Consumption of
highly processed palatable foods with motives to reduce
posttraumatic symptoms, such as hyperarousal, intrusive
images, and facilitate numbing has been associated with
BED, BN and bulimic behaviors in general [33, 37, 38].
Obese individuals with BED report a lower quality of life
than if either of those conditions exists alone [39]. While
maladaptive emotional regulation is a hallmark of BED,
weight or BMI is not considered criteria for diagnosis.
However, when there is BED and FA, obesity is likely to
occur [40]. For individuals who have successfully lost
weight, binge-eating behavior is the primary mechanism
behind weight regain [41]. Thus, BED treatment may
interrupt a steep weight gain trajectory [42].
Currently, the most common nutritional treatment for
BED appears to resemble the treatment for AN-R, where
patients are encouraged to liberalize their diet and learn to
consume all foods, including highly palatable foods, in
moderation. This treatment strategy might be effective for
a BED patient whose eating pathology stems from psy-
chologically based (e.g., shame) rather than biologically
based (chronic exposure to highly palatable foods) mech-
anisms, but may be less effective over a longer period of
time if the patient is FA primary. In other words, thera-
peutic interventions alone will not treat BED/FA if the
patient continues to eat addictively (clinical anecdote).
Approximately, one-fourth (27%) of BED patients have a
co-occurring SUD [43]. Shared mechanisms in addictive
disorders and BED include: reward dysfunction, craving,
emotion dysregulation, and impulsivity [44]. Recent find-
ings by Aloi et al. [45] suggest neurocognitive differences
between patients with AN (rigidity and attention to details)
compared to BED (lack of attention and difficulty adapting
to changes), which point to the need for different inter-
vention strategies. Meanwhile, many BED patients exhibit
food fears and restrictive eating patterns similar to AN
patients, hence the overlap shown in Fig. 1. It has been
suggested that BED be treated in a way that acknowledges
the presence of a range of binge-eating phenotypes [46]
and subtypes, including co-occurring SUD [43].
Food addiction (FA)
Food addiction has been described as a reward-responsive
phenotype of obesity [47] although FA can exist without
obesity [48] and without BED. Gearhardt et al. [40]
reported that approximately half of BED patients meet
criteria for FA utilizing the YFAS, suggesting the presence
of a more disturbed subset than BED or FA alone. Among
ED patients, probability of FA is predicted by high nega-
tive urgency, high reward dependence, and lack of
premeditation [49]. Not surprisingly, there is evidence that
FA can undermine efforts to lose weight related to
behavioral (e.g., tolerance and withdrawal) and neuro-
physiological (dopamine and endogenous opioid action in
the midbrain) pathology [50]. Alterations in dopamine
neurocircuitry observed in obese individuals can make
food less rewarding and more habitual [51]. Rates of
weight regain in weight-reduced obese individuals are
reminiscent of the high relapse rates for addiction [52].
Highly processed foods (refined grains, added sugars,
sweeteners, fats, and salt) that share characteristics of drugs
of abuse (e.g., high dose, rapid rate of absorption) are most
associated with food addiction [30]. These authors found
the combination of white flour, sugar, and fat (e.g., cookie)
to be the most addictive combination. Given the abundance
and easy access of highly palatable food, craving and
compulsion are an important construct to consider within
the biological context of EDs [8].
Dysfunction of the dopamine D2 receptor leading to
substance-seeking behavior (alcohol, drug, food) has been
termed reward deficiency syndrome (RDS), a concept that
unites addictive, impulsive, and compulsive behaviors [53].
RDS remains somewhat controversial as causal in addic-
tion and obesity. A recent review identified behavioral
changes related to the A1 allele (associated with RDS)
including novelty seeking, delay discounting, impulsivity,
and ability to avoid negative consequences as key mecha-
nisms behind hyperphagia [54]. Low availability of dopa-
mine D2 receptors in the nucleus accumbens reduces
activity in the prefrontal cortex, contributing to impulsivity
and poor self-control in obese individuals [55]. This rein-
forcement pathology favors unhealthy behaviors that con-
tribute to weight gain [56]. Alternatively, reward surfeit
theory suggests that individuals with greater reward region
sensitivity (rather than less) to substance-related cues are at
elevated risk for overeating, suggesting that habitual intake
of palatable foods leads to hyper-responsivity of attention
and reward valuation [57].
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While impaired dopaminergic signaling mechanisms
have been implicated in individuals with FA [58], recent
investigators have explored hormonal differences between
obese individuals who meet criteria for FA versus those
who do not [59]. The arcuate nucleus in the hypothalamus
is the integration site for blood-borne signals (e.g., hor-
mones, nutrients) that calibrate the brain reward system
governing hedonic feeding [60]. Several authors have
identified leptin as the indirect link between overeating and
addiction, since it has action extending to the brain reward
circuits influencing preference for highly palatable foods.
Leptin-deficient individuals could be classified as meeting
criteria for FA [61]. There is also evidence that the insulin
receptor signaling pathway interferes with leptin signaling,
suggesting that hyperinsulinemia may contribute to leptin
resistance [62]. Other reports implicate that the ghrelin
system (gut-derived) may alter the set point of the
dopaminergic neurons in the ventral tegmental area,
thereby enhancing the ability of rewarding substances to
activate the midbrain dopamine system [63, 64].
While it is outside the scope of this review to discuss the
various mechanisms of neurotransmitters and hormones
associated with disordered eating, emerging data should
direct new specific biological strategies when treating
patients with addictive symptoms. Recently, the gut
microbiome has received increased attention as a con-
tributing factor to obesity [65, 66] and EDs [67]. The gut-
brain axis involving receptors in the enteric nervous sys-
tem, the autonomic nervous system (including vagus
nerve), immune system, neuroendocrine system, systemic
circulation (including lymphatic), and the spinal cord
implies a ‘‘cross-talk’’ mechanism between gut microbiota
and the host brain [60, 68]. Fermentation byproducts of
fiber degradation by microorganisms include short chain
fatty acids (SCFAs) that are involved in the synthesis of
hormonal precursors, suggesting that SCFAs modulate the
enteric nervous system [69]. New insights suggest that the
composition of food consumed (e.g., fiber content, artificial
sweeteners) impacts the microflora, which in turn regulates
homeostasic mechanisms [70–72]. It is imperative that we
look beyond calories (quantity) towards the impact of food
(quality) on gut health when tailoring nutrition interven-
tions for disordered eating, particularly when hedonic
mechanisms appear to override homeostatic mechanisms.
The general public appears to support obesity treatment
through the lens of addiction [73], but believe that obese
individuals are personally responsible for their weight. The
food industry continues to deny responsibility for creating
obesogenic environments by continuing to stress individual
responsibility for eating, and continuing to emphasize
moderation. Put in perspective, educational efforts alone
have not reduced the use of illicit drugs. Recently, it has
been shown that belief in the addictive potential of a
substance or behavior creates support for policies intended
to curb their use [74]. Efforts to influence the food industry
(‘‘food environment’’) may be required to combat the rising
epidemic of FA, obesity, and many cases of BN and BED.
Psychological interventions (traditionally considered first-
line in the treatment of EDs) alone are not sufficient in FA.
There is a clear need to treat the gut, brain, and endocrine
system together for recovery efforts to be sustainable and
effective. For many patients with FA, it is ‘‘about the food’’
in addition to various underlying factors; therefore, highly
specified nutrition (and exercise) interventions should be
considered a primary part of a treatment program [75].
Substance use disorder (SUD)
Patients with SUDs share characteristics with compulsive
overeaters from brain imaging studies [10] and behavioral
models [76]. Individuals in early addiction recovery have
described dysfunctional eating such as bingeing to satisfy
drug cravings [77], leading to unhealthy and undesirable
weight gain [78]. Altered fat regulation observed in
cocaine-dependent men has been linked to lower levels of
circulating leptin [79], lending support to the significance
of hormones relative to addictive processes. Evidence that
gastric bypass patients develop new-onset SUDs/AUDs in
the post-surgical period (second year or later) suggests that
‘‘addiction transfer’’ is a likely phenomenon that may
require specialized treatment [80–82]. Interestingly, there
is evidence of reduced appeal of high-energy foods in
patients after gastric bypass [83] suggesting changes in
brain reward that may be linked to alterations in gut
microbiota. Several diagnostic characterisitics of SUD
overlap with BED, such as using larger amounts than
intended, continuing to consume despite negative conse-
quences, and reducing other pleasurable activities due to
consumption. Currently there is a need for empirically
supported treatments for co-occurring SUD and ED [84].
ED symptoms have been significantly associated with
treatment rejection among young adult men in residential
SUD treatment, suggesting that comorbid ED and SUD are
a higher risk clinical group [85]. Thus, SUD is associated
with BN, BED, and FA in Fig. 1.
The disordered eating food addiction nutrition
guide (DEFANG)
The bottom half of the DEFANG describes classic ED
treatment that is seemingly geared toward the underweight
patient with AN where it is often times ‘‘not about the
food’’. This is not to suggest that weight restoration via
nutrition therapy is not of paramount importance in the
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treatment of AN, but rather it is not the primary focus in the
larger scheme (after re-feeding and stabilization). In many
cases, the AN patient will insist that it is ‘‘about the food’’
and thus be resistant to a meal plan. The big picture
treatment goals are to make peace with food by overcom-
ing dietary fears and unnecessary restrictions (liberalize the
diet, apply moderation), make peace with body by engag-
ing in therapy addressing body image, and in many cases
psychotropic medication to stabilize mood and to lower
obsessional anxiety. Psychotherapeutic interventions are
considered the ‘‘big picture’’ foundation of treatment, with
nutrition and physical wellness (e.g., exercise) being sec-
ondary. In other words, nutrition and exercise interventions
alone are not sufficient treatment for AN. If the patient
does not begin to make some peace with food and body,
recovery is not likely to be sustainable.
The upper half of the DEFANG proposes treatment
strategies for the overweight/obese patient with FA, dis-
playing clear signs of addiction (e.g., tolerance and crav-
ing) and compulsion around food intake. These cases are
more likely to be ‘‘about the food’’, thus containing bio-
logical underpinnings that must be addressed in treatment.
Treatment goals are to stabilize the body (e.g., gut, hor-
mones) and begin to heal the dysfunctional brain circuitry
that persists in addiction. This will require a restricted diet
with reduced exposure to highly palatable foods and caloric
upper limits. ‘‘Restricted’’ does not mean eliminating food
groups or utilizing low calorie diets, but rather restricting
the excessive and undesirable consumption that is charac-
teristic of substance-related addictive disorders. Nutrition
and exercise interventions should thus be considered key
components. Therapy and/or medication may be important
in the treatment of FA, but it is insufficient to address the
physical ramifications associated with substance abuse
alone. However, therapeutic interventions that are designed
to support the journey towards stabilization of the body and
brain can prevent the patient from fostering disordered
thinking, such as placing too much emphasis on weight or
developing irrational food fears, and will be critical for
sustainable recovery.
Assessment and plotting of patients with BN and BED
using the DEFANG may prove to be helpful for case
conceptualization. If a patient displays classic ED psy-
chopathology (akin to AN), they will be placed in the
bottom half of the model, whereas a client displaying
addictive symptomatology will be plotted in the upper half.
The upper left corner represents the obese food addict with
BED, whereas the bottom right corner represents the
underweight restrictive eater (AN or BN). Movement
towards either of these corners reflects weight/BMI status,
which will be useful in painting a more complete picture. It
can also be useful to specify severity as outlined in the
DSM-5 (mild, moderate, severe, extreme). If a patient is
plotted near the mid-section of the diagram, they will
benefit from a combination of treatment approaches, which
should be determined by the clinical staff. For example, a
BED patient in the upper half (but near the middle) of the
DEFANG may benefit from having dessert only once or
twice per week whereas a BED patient in the lower half
may require dessert more often. Furthermore, a patient with
BN on the lower half of the model may be better suited in a
milieu with anorexics (liberalized diet), whereas a BN
patient in the upper half may benefit from targeted edu-
cation about the potential impact of food processing on
eating behavior. A middle-ground message can be: ‘‘All
foods fit. But not all foods fit for all people. And just
because the food industry manufactures and sells it, does
not mean we have to include it’’.
Case study
History
A 46-year-old, 180.5 kg (BMI = 59), woman with a his-
tory of depression entered residential treatment for BED in
June 2015. While the patient had never been to a treatment
center before, she had been treated for depression and had
seen a therapist intermittently for the past 14 years, mostly
at age 32 (2001).
She described both of her parents as well as her
grandparents being alcoholics. She reported that her mother
was ‘‘skinny’’, but her father battled with his weight his
entire life. The patient was the victim of sexual trauma at
age 9 but was never diagnosed with PTSD, or formally
treated for it (aside from trauma-informed group therapy
utilizing psychodrama techniques during treatment). At age
11, she learned how to count calories and exercise with her
parents. The patient stated that she had been on many diets
in her lifetime, including Jenny Craig, Weight Watchers,
and Atkins [86]. She began binge drinking in high school
and described herself as a ‘‘blackout drunk’’. During her
twenties, she was a heavy social drinker and often drank to
excess. At this time, she also used cocaine, marijuana, and
crystal meth briefly. She reported that food had always
been her primary addiction but stated ‘‘If I’m eating, I’m
usually drinking’’ preferring starchy/fatty/salty foods to
sweet foods, with her favorites being cheeseburger, pizza,
pasta, French fries, bread, and ice cream. The patient states
that she eats large amounts of food all day long, consis-
tently seeking a ‘‘full’’ feeling. She does not endorse
restrictive eating patterns that are common with BED
patients, although she will wait until she has privacy and
‘‘complete comfort’’ to eat her favorite foods.
The patient’s weight reached approximately 136 kg in
2005. She utilized the 12-Step program Compulsive Eaters
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Anonymous–Honesty, Open-mindedness, Willingness
(CEA-HOW) and lost 68 kg by adhering to a rigid food
plan, attending meetings, and working the Steps with a
sponsor. The patient described feeling that for the first time
in her life that she was ‘‘not a slave’’ to food, being a
‘‘different person’’ and experiencing internal freedom. She
also stopped drinking alcohol and using drugs at that time
and maintained her sobriety and weight at 68 kg for
6 months until she became pregnant. Unfortunately, the
patient moved to another area where there was no CEA-
HOW meetings, and stopped actively working her recovery
program. After being separated from her recovery program,
the patient distinctly recalls eating a Reuben sandwich and
then ‘‘decided’’ to reincorporate bread back into her diet,
which led to rapid weight gain. Although she tried to revert
back to her CEA-HOW food plan, she was unsuccessful
and could not ‘‘put 30 days together.’’
The patient got married in 2007, but gained 45 kg
shortly after the wedding. She divorced in 2010 and
struggled with her weight as a single mom (ranging from
136 to 181 kg), reporting that her son also struggled with
food and weight issues. The patient did not seek psy-
chotherapy at this time despite the fact that she reported
being very challenged by the stressors of life as a single
mother. In 2012, the patient found CEA-HOW meetings
online and utilized Alcoholics Anonymous (AA) to get
sober and lose 45 kg. Sadly, as a single mom, the patient
could not stay connected to the program and maintain her
recovery.
Treatment
The patient entered residential treatment for BED in June
2015 and remained there for 4 months. The patient was
started on citalopram 40 mg for depression, which was
helpful. She was convinced that she needed a structured
abstinence-based approach towards eating, stating that
throughout her entire life she had never been able to eat in
‘‘moderation’’. After a comprehensive intake and assess-
ment by Registered Dietitian Nutritionist (RDN) and use of
the YFAS combined with the DEFANG, it was determined
that she belonged to the uppermost portion of the model,
towards the upper left corner (see Fig. 2). The patient and
RDN agreed on a nutritional treatment plan that involved
no dessert and no exposure to highly palatable foods. She
understood that she was receiving treatment for her food
addiction, affirming that she only came to treatment
because she knew it would be addressed as an addiction,
rather than a classic eating disorder. The patient was
resistant to the message of ‘‘body acceptance’’ and ‘‘body
positivity’’ presented to her during treatment.
The patient was put on a meal plan that included 3 meals
and 3 snacks (2400–2600 kcal), with several options for
breakfast and snacks. Her meal plan included representa-
tion from all food groups several times/day that was high in
dietary fiber. The patient did not consume highly palat-
able foods in treatment, specifically no fried foods, white
flour, or foods with added sugar. The patient eagerly
attended weekly OA meetings during treatment and con-
nected with a sponsor. She exercised with a trainer 99/
week, with 2 workouts 3 days/week and one rest day. The
patient was weighed ‘‘blind’’ during treatment, with the
plan to discuss her weight at the halfway point (60 days)
and at discharge. At day 60, the patient had lost 13.6 kg but
was very upset with her modest weight loss. This patient
spent a large portion of her life equating her weight with
her self-worth and had a difficult time acknowledging her
mental, emotional, and spiritual recovery. The patient had
previously lost 45? kg on a CEA-HOW (low calorie) meal
plan (3 meals, no snacks) on two separate occasions. She
was tearful and threatened to leave treatment but was
convinced to stay by the clinical staff. Her treating RDN
explained that low calorie meal plans result in rebound
bingeing and eventually lead to rebound weight gain, and
that she was put on a meal plan and calorie level that she
could more realistically sustain over time. In conjunction
with her primary therapist, her meal plan was reduced to 3
meals, 2 snacks (2000–2200 kcal). She also engaged in
cooking classes during treatment and was taught to ‘‘plate’’
her own food and eyeball her portions. The patient was
discharged with this meal plan (3 meals, 2 snacks) and was
instructed not to ‘‘diet’’ (count calories, weigh and measure
food, etc.). She discharged weighing 146.5 kg.
Follow-up
The patient followed her discharge meal plan and did not
eat foods determined to be addictive (fried foods, white
flour, and added sugars). She got a job at a gym as a
membership representative and exercised on most days.
The patient became involved in Overeaters Anonymous
(OA), began working with a sponsor who kept her
accountable and she gradually lost another 22.7 kg (down
to 123.8 kg) while continuing outpatient psychotherapy.
Eventually, in an attempt to reduce ‘‘black and white
thinking’’, the therapist recommended that she should eat
in ‘‘moderation’’. At first resistant, she recalls: ‘‘the addict
in me thought this was a really good idea’’. The patient
then had a ‘‘slip’’ on sugar while losing the motivation to
exercise regularly. She gained 13.6 kg in only 2 months
while struggling to ‘‘get back’’ due to general life stress.
At recent follow-up, the patient reported weighing 138 kg
and continued to struggle with her food addiction,
although most recently she was re-engaged with CEA-
HOW phone bridge meetings and had a renewed sense of
optimism.
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Conclusion
The treatment for EDs should vary based on the individ-
ualized assessment and diagnosis. All patients entering ED
treatment should not receive the same type of food and
generic nutrition education. Using the DEFANG, treatment
teams can provide consistent ED-informed messages that
are consistent with the patient diagnosis, and that can
challenge self-destructive ‘‘black-and-white thinking’’.
Meanwhile, educational components can acknowledge the
profound impact that contemporary food has on the human
gut, brain, and endocrine system. Providers should explore
these concepts with their patients and be willing to validate
their difficulties navigating the food supply. Food addiction
is a valid construct that should be incorporated into the
spectrum of disordered eating, particularly for those
patients with BN, BED, and co-occurring addictive disor-
ders (FA or SUD). Further research on brain structure and
function will help better model the complex interaction
between EDs, SUDs, and addictions. Currently, there is no
consensus on how to most effectively treat FA; therefore,
efforts to identify more specific nutrition intervention
strategies are clearly needed.
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